GPT and metabolic dysfunction-associated steatotic liver disease: Their data demonstrated that silymarin was able to reduce the biochemical and histopathological changes induced by high-fat diets in a rat model of NAFLD, inducing a significant reduction in serum cholesterol, triglycerides, AST and ALT in the treated group compared to the non-treated group [48].